Inventor · Jamestown, NC, US

Mustafa Guzel

35Patents
8h-index
43Co-inventors
75Inventor score

Filing activity: Oct 6, 2003 → Apr 3, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7384967B2 Aryl carbonyl derivatives as therapeutic agents Chemistry; Metallurgy 149 Expired
US7541373B2 Aryl carbonyl derivatives as therapeutic agents Chemistry; Metallurgy 123 Active
US7459472B2 Aryl and heteroaryl compounds, compositions, and methods of use Chemistry; Metallurgy 93 Expired
USRE45670E1 Aryl carbonyl derivatives as therapeutic agents General 33 Active
US7897628B2 Aryl carbonyl derivatives as therapeutic agents Chemistry; Metallurgy 14 Active
US8759535B2 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 12 Active
US10287284B2 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 12 Active
US7906507B2 Oxadiazoanthracene compounds for the treatment of diabetes Chemistry; Metallurgy 9 Active
US8329715B2 Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors Emerging Cross-Sectional Technologies 8 Active
US7727983B2 Oxadiazoanthracene compounds for the treatment of diabetes Chemistry; Metallurgy 7 Active
US7790714B2 Oxadiazoanthracene compounds for the treatment of diabetes Chemistry; Metallurgy 7 Active
US9393245B2 Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors Emerging Cross-Sectional Technologies 5 Active
US8063081B2 Aryl carbonyl derivatives as therapeutic agents Chemistry; Metallurgy 5 Active
US8524708B2 Oxadiazoanthracene compounds for the treatment of diabetes Chemistry; Metallurgy 4 Active
US8703766B2 Oxadiazoanthracene compounds for the treatment of diabetes Chemistry; Metallurgy 4 Active
US9120813B2 Oxadiazoanthracene compounds for the treatment of diabetes Chemistry; Metallurgy 3 Active
US10030011B2 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 2 Active
US10889580B2 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 2 Active
US10570126B2 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 2 Active
US11130753B2 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 2 Active
US8933222B2 Oxadiazoanthracene compounds for the treatment of diabetes Chemistry; Metallurgy 2 Active
US11649230B2 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 1 Active
US8987295B2 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof Chemistry; Metallurgy 1 Active
US10568888B2 Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors Emerging Cross-Sectional Technologies 1 Active
US9175003B2 Substituted azoanthracene derivatives and intermediates for preparation thereof Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.